Stock News

Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) Meets Primary Endpoint Of Progression-Free Survival
Amgen Highlights New Data From KYPROLIS® (carfilzomib) And Oncology Pipeline At IMW 2019
deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants
Amgen Falls 3%

As seen on...